Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 250K 500K 750K FY24: 430K FY25: 704K FY24 FY25

Gross Profit Annual

-45K -30K -15K 0 15K 30K 45K FY16: -34K FY17: 0 FY16 FY17

Operating Income Annual

-9M -6M -3M 0 3M 6M 9M FY24: -7.7M FY25: -6.9M FY24 FY25

Net Income Annual

-9M -6M -3M 0 3M 6M 9M FY24: -7.7M FY25: -6.9M FY24 FY25

Cost of Revenue Annual

0 250K 500K 750K FY24: 270K FY25: 646K FY24 FY25

Operating Cash Flow Annual

-6M -4M -2M 0 2M 4M 6M FY24: -4.9M FY25: -3.8M FY24 FY25

Free Cash Flow Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M FY23: -7M FY24: -4.9M FY23 FY24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 6M 12M 18M FY24: 14.8M FY25: 16.5M FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.60 -0.40 -0.20 0.00 0.20 0.40 0.60 Q3 '24: -0.58 Q4 '24: -0.53 Q1 '25: -0.48 Q2 '25: -0.41 Q3 '25: -0.39 Q4 '25: -0.41 Q1 '26: -0.40 Q2 '26: -0.39 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.